2010•Zhongguo yiyuan ganranxue zazhiRequires access

Cost-effectiveness analysis of three therapeutic schemes in treatment of children's pneumonia.

Yan Fu-qin, LI Dong-mei, Sun Hui-ping, LüJuanLi, Ying Liu

Abstract

OBJECTIVE To discuss the cost-effectiveness of three therapeutic schemes in the treatment of children′s community-acquired pneumonia.METHODS Totally 118 cases of pneumonia patients were divided into the three groups including cefuroxime sodium(A) ceftriaxone(B) and cefotaxime sodium(C) treatment groups.The cost-effectiveness relation was evaluated with the method of pharmacoeconomic cost-effectiveness analysis.RESULTS The recovery rates of the three groups were 72.50%,84.62% and 87.18%(P0.05);the costs of three groups were(1110.46 ± 156.26) yuan,(1110.80 ± 120.27) yuan and(2405.52 ± 325.36) yuan(P0.05);the cost-effectiveness scores were 15.32% 13.13%,and 27.59%.No adverse reaction appeared in all the 3 groups.CONCLUSION The cefuroxime sodium scheme in the treatment of children′s pneumonia is a preferable choice.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Pneumonia, Cefuroxime, Medicine, Ceftriaxone, Community-acquired pneumonia, Adverse effect, Intensive care medicine, Internal medicine